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ABSTRACT

We have developed a primer-mediated PCR mutagenesis-based method for the generation of positive controls to test the sensitivity of single-strand conformation polymorphism (SSCP) or any other PCRbased mutation screening method. This technique is based on the incorporation of a third longer primer, containing a mismatched base, into the PCR along with the two wild-type primers normally used to amplify DNA fragments for SSCP analysis. The longer mismatch primer (LMP) shares the sequence of one of the wild-type primers and also contains 5 to 10 additional bases, which include the mismatched base. The resulting PCR product is identical in length
INTRODUCTION
The definitive method for the detection of mutant alleles is the direct sequencing of polymerase chain reaction (PCR) products (10) , but this is tedious, time-consuming and costly when working with a large number of samples. For this reason, several methods of screening for mutations in DNA sequences have appeared (3) with the aim of analyzing the greatest number of patients and loci in the shortest possible time and at reasonable cost. One of the techniques most commonly used is singlestrand conformation polymorphism (SSCP) analysis (9) . When faced with searching for allelic variants in a gene that has not been analyzed previously, it is very beneficial to use positive control material, such as DNA from individuals with previously characterized mutations to be confident that the conditions used are sensitive enough to detect all variants. Otherwise, negative SSCP results could be due to inappropiate SSCP conditions rather than the absence of variants.
The incorporation of point mutations is a recurrent topic in PCR applications and is the simplest method for modifying DNA sequences during amplification (4). This technique is based on the principle of hybridizing primers with mismatched bases under determined conditions (7, 8, 13) .
Here we present a simple PCR-mediated mutagenesis method for generating mutated controls to be used to evaluate the sensitivity of SSCP conditions. The addition of a third longer primer with a mismatched base in the area not shared by the wild-type primer, longer mismatch primer (LMP), to the PCR tube of an individual (negative control) permits the in vitro generation of a positive control during PCR. To our knowledge, this is the first report of PCR mutagenesis being used for the generation of positive controls to evaluate SSCP sensitivity. In addition to the two wild-type primers, 5 pM of a LMP containing a nucleotide (nt) substitution (A for a G) at position 829 of exon 1 of the RDS/human peripherin gene are added to three different control reactions selected to be mutated. The sequence of the LMP is 5 ′ TCTGACCCCAGGAC -TGGAAGTCACT 3 ′ .
MATERIALS AND METHODS
In
The underlined sequence is shared by both the wild-type antisense primer and the LMP. Extension of the LMP during the PCR generates a PCR product that contains an A to G transition at position 829 of exon 1 of RDS/human peripherin gene.
The PCR conditions are: an initial denaturation for 5 min at 94°C, followed by 30 cycles of 94°C for 30 s, 65°C for 1.5 min and a final extension at 74°C for 5 min.
The 342-bp PCR product is larger than the optimum size needed for analysis by SSCP (3). Therefore, before SSCP analysis, the product is digested with an endonuclease (5) . In this case, Msp I (Boehringer Mannheim) was used according to manufacturer's recommendations. The digestion generates two fragments of 156 and 186 bp; the 186-bp fragment harbors the base mutated in vitro. In the 156-bp fragment generated by this method, it is possible to detect the polymorphism (nt 558 C to T) described by Farrar et al. (1) .
Digested samples are diluted to a final volume of 75 µ L, then 3 µ L of each sample are mixed with 3 µ L of SSCP stop solution/loading buffer (95% formamide, 20 mM EDTA, pH = 8.0, 0.05% bromophenol blue, 0.05% xylene cyanole), denatured for 5 min at 97°C and chilled on ice. Samples are loaded on a 4-mm-thick, nondenaturing 0.5 × MDE ™ Gel (AT Biochem, Malvern, PA, USA) containing 10% glycerol and 0.6 ×TBE buffer (Boehringer Mannheim). Electrophoresis is carried out using 0.6 × TBE buffer overnight at room temperature with the power fixed at 6 W. The gel is dried and subjected to autoradiography at -80°C for 24 h. Figure 1 shows the results of this experiment.
In Vitro Mutagenesis of Additional DNA Target Sequences
To demonstrate that our experimental approach can be used to introduce point mutations into any DNA sequence, we include experimental details for three additional in vitro mutagenesis experiments in Table 1 . A single-base deletion (Experiment 2) and a G to T transversion (Experiment 3) are created in exon 2 of the RDS/human peripherin gene. A C to T transition is introduced in intron C of the rhodopsin gene (6) (Experiment 4). Experimental conditions not shown in Table 1 are identical to those described above for exon 1 of RDS/human peripherin (bp 508-849). Figure 2 shows results of SSCP analyses performed using the mutated segments. Each experiment has been repeated several times, obtaining identical results (data not shown). Figure 1 shows the results of SSCP analysis of exon 1 of the RDS/human peripherin gene. The lanes corresponding to the PCRs where the LMP was added (*) have an identical altered migration pattern for one of the bands of the 186-bp fragment, whereas the PCRs without the LMP share the normal pattern shown in lanes 1-5. It is interesting to note that in the reactions containing LMP, the wild-type band has completely disappeared. This suggests that close to 100% of the product has the mutation incorporated. In the lower section of Figure 1, fragment are shown (for details see legend for Figure 1) . Figure 2 shows the results of three additional SSCP analyses using positive controls generated in mutagenesis Experiments 2, 3 and 4. Lane 5 of Figure 2A shows the SSCP pattern of an in vitro transition mutation (nt 4076 C to T) in intron C of the rhodopsin gene generated in Experiment 4 (for details see Table 1 and legend for Figure 2) . Figure 2B shows SSCP analysis of exon 2 of the RDS/human peripherin gene and its flanking sequences. In this experiment, two different LMPs [one forward LMP (fLMP) and one reverse LMP (rLMP)] were used in two separate PCRs to test SSCP sensitivity in the two fragments (180 and 136 bp) generated after Sac I (Boehringer Mannheim) digestion of the PCR product. The fLMP (Experiment 2) creates a base pair deletion at position 25 of exon 2 of the RDS/peripherin gene. The abnormal SSCP pattern generated can be seen in lane 6 of Figure 2B . In this case, the migration pattern is not altered; one of the 180-bp fragment bands that does appear in the wild-type SSCP pattern (lane 8), does not appear. This same pattern has been observed repeatedly (data not shown), and further experiments must be performed to evaluate the behavior of this single-base deletion under our SSCP conditions. The rLMP (Experiment 3) creates a single-base transversion (G to T) at position 294 (for details see Figure 2 and Table 1 ). This mutation generates an aberrant migration of both strands of the 136-bp fragment ( Figure 2B, lane 7) . In this case, the wild-type product is absent.
RESULTS AND DISCUSSION
The sensitivity of the SSCP technique has not been studied sufficiently (10) , and evaluation of SSCP sensitivity has been complicated by the absence of positive controls. In addition, "the use of positive controls is a valuable aid to confident interpretation" (12) . Here we show four different experiments using primer-mediated in vitro mutagenesis with the same result: the generation of an aberrant SSCP pattern. Mutagenesis through the addition of an LMP in the PCR of a control individual represents a rapid, easy and economical method for producing positive controls for SSCP or any other PCR-based mutation screening methodology. This mutagenesis approach should prove useful regardless of the pathology being studied.
Remarkably, our experimental approach permitted us to generate mutated controls in one step during the PCR. The mismatched base incorporated lies outside the wild-type primer sequence used to amplify the DNA segment. Both the wild-type primer and the LMP that introduces the single base change are added to the PCR without the risk of reversion to the wild-type product during the PCR. A preceeding step to generate the mutation is not necessary. Since the LMP is always extended at the 3 ′ end, the final product is identical in size to the control segment being amplified (with exception of deletions). More importantly, the mutation is introduced into the exact sequence context as the control template, and the DNA region to be screened.
The reason why the alteration is produced in 100% (or close to 100%) of the PCR product is not clear. Initially, we expected that adding two primers that recognize the same target in the DNA sample would result in competitive annealing (2) and the amplification of both products. However, our results suggest that the greater size of the LMP favors its annealing. This may be due to "co-annealing" of both primers, which obligates extension of the longer primer. On the other hand, an exponential loss of wild-type product could take place during PCR amplification.
With the use of our experimental approach, only positions that are close to the ends of PCR products can be mutated. Nevertheless, we feel that the generation of positive SSCP controls through the use of LMPs may be useful for interpreting band patterns and in setting up of individually optimized experimental conditions for a specific SSCP target fragment.This should help to reduce the number of false negatives when screening for mutations using SSCP or any other PCR-based mutation screening procedure.
Obviously this method does not solve the problem of SSCP controls completely. The detection of a single change does not mean that the conditions used can detect 100% of mutation possibilities. However, the observation of an aberrant SSCP pattern provides confirmation that the method has been performed correctly. In addition, a negative with an in vitro-mutated positive control serves as a signal that SSCP conditions should be revised. However, control materials may not always be available for the DNA region to be analyzed, particularly when screening for mutations not previously reported. In vitro-generated mutations can be used as a complement to a set of previously characterized mutated samples. In addition, in vitro-generated controls could be useful in the development of novel mutation detection methods. 
